Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Retained Earnings: 2011-2019

Historic Retained Earnings for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Mar 2019 value amounting to -$427.7 million.

  • EyePoint Pharmaceuticals' Retained Earnings fell 29.79% to -$427.7 million in Q1 2019 from the same period last year, while for Mar 2019 it was -$427.7 million, marking a year-over-year decrease of 29.79%. This contributed to the annual value of -$364.0 million for FY2018, which is 17.11% down from last year.
  • As of Q1 2019, EyePoint Pharmaceuticals' Retained Earnings stood at -$427.7 million, which was down 4.71% from -$408.5 million recorded in Q4 2018.
  • In the past 5 years, EyePoint Pharmaceuticals' Retained Earnings ranged from a high of -$265.5 million in Q1 2015 and a low of -$427.7 million during Q1 2019.
  • For the 3-year period, EyePoint Pharmaceuticals' Retained Earnings averaged around -$353.5 million, with its median value being -$329.6 million (2018).
  • Per our database at Business Quant, EyePoint Pharmaceuticals' Retained Earnings grew by 2.76% in 2015 and then fell by 29.79% in 2019.
  • EyePoint Pharmaceuticals' Retained Earnings (Quarterly) stood at -$280.8 million in 2015, then dropped by 6.64% to -$299.4 million in 2016, then decreased by 7.73% to -$322.6 million in 2017, then decreased by 26.63% to -$408.5 million in 2018, then declined by 29.79% to -$427.7 million in 2019.
  • Its last three reported values are -$427.7 million in Q1 2019, -$408.5 million for Q4 2018, and -$396.9 million during Q3 2018.